Sign in with Google
bullish
A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
422 Views08 Nov 2020 01:57
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation of RemeGen from a different angle.
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Hang Seng Indexes: ADR Depositary Holding Changes; Round-Trip Trade Is US$5.1bn; NetEase Outperforms
- Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations
- MongoDB (MDB US): Fast-Exit from Nasdaq100 in May 2025
- Rare Arb Opportunity from ATS Breakout in Korea: Day-Night Spread
- Quiddity Leaderboard TDIV Jun25: US$2.5bn One-Way; Several High-Impact Flow Names
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Antengene - Insights on Pipeline and Valuation18 Nov 2020
- China Healthcare Weekly (Nov.13)17 Nov 2020
- China Healthcare Weekly (Nov.6)10 Nov 2020
- JW Therapeutics - Concerns Are in the Short Term but Still Promising in the Long Term28 Oct 2020
- Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC4823 Oct 2020
- A Different Angle - Simcere Pharmaceutical VS Everest Medicines (01952.HK)11 Oct 2020
x